Pioneering French oncologist Mathe dies at 88

Oct 18, 2010

(AP) -- Oncologist Georges Mathe, who in 1959 performed the world's first bone marrow transplant, has died, the French president's office said Monday. He was 88.

Nicolas Sarkozy's office said Mathe died on Friday, but did not provide any additional details.

"His contribution to the progress of remains major," the statement said. "In 1959, he performed the first bone marrow transplants on six Yugoslav physicians who had been accidentally irradiated at a nuclear power plant. Four of them survived."

Mathe was the first physician to use bone marrow transplantation to treat leukemia. The procedure involves giving patients a high dose of and radiation to kill cells. Transplanting bone marrow is also used to treat radiation and blood diseases including sickle cell anemia.

Mathe founded a specialized cancer center in the Paris suburb of Villejuif in the early 1960s and ran its blood disease unit until 1990, the statement said.

Explore further: New type of targeted therapy shows promise in preclinical models of B-cell malignancy

not rated yet
add to favorites email to friend print save as pdf

Related Stories

Research shows cord blood comparable to matched bone marrow

Jun 08, 2007

University of Minnesota researchers report that umbilical cord blood transplants may offer blood cancer patients better outcomes than bone marrow transplants, according to an analysis of outcome data performed at the Center ...

Molecule dictates how stem cells travel

Jan 14, 2006

U.S. researchers have defined a molecule that dictates how blood stem cells travel to the bone marrow and establish blood and immune cell production.

Recommended for you

The fine line between breast cancer and normal tissues

15 hours ago

Up to 40 percent of patients undergoing breast cancer surgery require additional operations because surgeons may fail to remove all the cancerous tissue in the initial operation. However, researchers at Brigham ...

Pancreatic cancer risk not higher with diabetes Rx DPP-4i

16 hours ago

(HealthDay)—There is no increased short-term pancreatic cancer risk with dipeptidyl-peptidase-4 inhibitors (DPP-4i) compared to sulfonylureas (SU) and thiazolidinediones (TZD) for glycemic control, according ...

Good bowel cleansing is key for high-quality colonoscopy

19 hours ago

The success of a colonoscopy is closely linked to good bowel preparation, with poor bowel prep often resulting in missed precancerous lesions, according to new consensus guidelines released by the U.S. Multi-Society Task ...

User comments : 0